|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.26 USD | +3.49% |
|
+8.17% | -44.70% |
| 06-29 | Keros Therapeutics, Inc.(NasdaqGM:KROS) added to Russell Microcap Value Benchmark Index | CI |
| 06-29 | Keros Therapeutics, Inc.(NasdaqGM:KROS) added to Russell 3000E Index | CI |
| Market Cap | 223M 195M 179M 167M 316M 21.22B 321M 2.15B 834M 10.41B 837M 819M 35.86B | P/E 2026 * |
-1.88x | P/E 2027 * | -2.06x |
|---|---|---|---|---|---|
| Enterprise Value | 223M 195M 179M 167M 316M 21.22B 321M 2.15B 834M 10.41B 837M 819M 35.86B | EV / Sales 2026 * |
52.4x | EV / Sales 2027 * | 11.8x |
| Free-Float |
46.57% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Keros Therapeutics, Inc.
| 1 day | +3.49% | ||
| 1 week | +8.17% | ||
| Current month | +5.23% | ||
| 1 month | +6.73% | ||
| 3 months | -6.17% | ||
| 6 months | -39.27% | ||
| Current year | -44.70% |
| 1 week | 10.57 |  | 11.42 |
| 1 month | 9.69 | | 11.47 |
| Current year | 9.69 | | 20.34 |
| 1 year | 9.69 | | 22.55 |
| 3 years | 9.12 | | 73 |
| 5 years | 9.12 | | 73 |
| 10 years | 9.12 | | 88.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jasbir Seehra
CEO | Chief Executive Officer | 70 | 30/11/2015 |
Keith Regnante
DFI | Director of Finance/CFO | 56 | 31/01/2020 |
Jennifer Lachey
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Jasbir Seehra
CHM | Chairman | 70 | 30/06/2024 |
Julius Knowles
BRD | Director/Board Member | 63 | 31/03/2016 |
Nima Farzan
BRD | Director/Board Member | 50 | 29/02/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-14 | Buy | Chairman | 1,000 | 0.0051% | ||
| 06-10 | Sell | Director | -550 | 0.0028% | ||
| 06-03 | Sell | Director | -2,625 | 0.0133% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.49% | +8.17% | -16.03% | -71.98% | 223M | |
| +0.68% | +5.00% | +78.89% | +135.72% | 58.73B | |
| +2.32% | +5.89% | +76.81% | +99.20% | 53.92B | |
| -10.61% | +8.38% | -9.90% | -9.62% | 24.67B | |
| -0.30% | +6.82% | +13.60% | +428.91% | 24.19B | |
| +4.74% | +13.47% | +46.43% | +0.03% | 18.8B | |
| -0.29% | +9.58% | +44.35% | -28.08% | 17.61B | |
| 0.00% | +16.74% | +171.12% | +355.99% | 16.25B | |
| +3.50% | +4.92% | +26.07% | +192.26% | 14.04B | |
| +6.72% | +20.94% | +51.67% | - | 13.9B | |
| Average | +2.81% | +7.52% | +48.30% | +122.49% | 24.23B | |
| Weighted average by Cap. | +2.20% | +6.00% | +59.32% | +137.60% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.25M 3.72M 3.41M 3.18M 6.03M 405M 6.13M 41.08M 15.92M 199M 15.97M 15.62M 684M | 18.91M 16.52M 15.17M 14.15M 26.83M 1.8B 27.28M 183M 70.8M 883M 71M 69.46M 3.04B |
| Net income | -120M -105M -96.65M -90.13M -171M -11.47B -174M -1.16B -451M -5.62B -452M -442M -19.38B | -132M -115M -106M -98.76M -187M -12.56B -190M -1.28B -494M -6.16B -496M -485M -21.24B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | US$11.26 | +3.49% | 403,611 |
| 01/07/26 | US$10.88 | +1.68% | 210,616 |
| 30/06/26 | US$10.70 | -2.10% | 289,055 |
| 29/06/26 | US$10.93 | -0.55% | 353,292 |
| 26/06/26 | US$10.99 | +5.57% | 1,433,696 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KROS Stock
Select your edition
All financial news and data tailored to specific country editions
